Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 7 is a BTB-Kelch-related protein encoded by the KLHL7 gene in humans. It functions as a substrate-specific adaptor for a BTB-CUL3-RBX1 E3 ubiquitin ligase complex, mediating the ubiquitination and degradation of specific substrate proteins. KLHL7 contains BTB/POZ, BACK, and Kelch domains, which allow protein-protein interactions and confer substrate specificity for ubiquitination machinery. Mutations in KLHL7 are associated with autosomal dominant retinitis pigmentosa (type 42) and other inherited retinal diseases. KLHL family members, including KLHL7, play diverse roles in protein quality control, cell morphology, and gene expression, and are involved in human disease, particularly neurodegenerative and Mendelian disorders.
Mediates ubiquitination and subsequent degradation of substrate proteins through the BTB-CUL3-RBX1 E3 ligase complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 7 (KLHL7).